Page 24 - Hematology_ Basic Principles and Practice ( PDFDrive )

Contributors xxi

Theodore E. Warkentin, MD David A. Williams, MD
Professor, Departments of Pathology and Molecular Medicine and Senior Vice President and Chief Scientific Officer, Boston
Medicine, Michael G. DeGroote School of Medicine, McMaster Children’s Hospital; President, Dana-Farber/Boston Children’s
University; Regional Director, Transfusion Medicine, Hamilton Cancer and Blood Disorders Center; Leland Fikes Professor of
Regional Laboratory Medicine Program; Hematologist, Service of Pediatrics, Harvard Medical School, Boston, Massachusetts
Clinical Hematology, Hamilton General Hospital, Hamilton Health Principles of Cell-Based Genetic Therapies
Sciences, Hamilton, Ontario, Canada
Thrombocytopenia Caused by Platelet Destruction, Hypersplenism, or Wyndham H. Wilson, MD, PhD
Hemodilution Senior Investigator, Lymphoid Malignancies Branch, National
Heparin-Induced Thrombocytopenia Cancer Institute, National Institutes of Health, Bethesda, Maryland
Diagnosis and Treatment of Diffuse Large B-Cell Lymphoma and
Melissa P. Wasserstein, MD Burkitt Lymphoma
Associate Professor, Departments of Pediatrics and Genetics, Albert
Einstein College of Medicine; Chief, Division of Pediatric Genetic Joanne Wolfe, MD, MPH
Medicine, The Children’s Hospital at Montefiore, New York, New Associate Professor of Pediatrics, Harvard Medical School; Division
York Chief, Pediatric Palliative Care, Department of Psychosocial
Lysosomal Storage Diseases: Perspectives and Principles Oncology and Palliative Care, Dana-Farber Cancer Institute;
Director, Pediatric Palliative Care, Department of Medicine,
Ann Webster, PhD Children’s Hospital Boston; Associate Professor of Pediatrics,
Director, Mind/Body Program for Cancer, Department of Harvard Medical School, Boston, Massachusetts
Psychiatry, Benson-Henry Institute for Mind/Body Medicine at Palliative Care
Massachusetts General Hospital, Boston, Massachusetts
Integrative Therapies in Patients With Hematologic Diseases Lucia R. Wolgast, MD
Assistant Professor of Pathology, Albert Einstein College of
Daniel J. Weisdorf, MD Medicine; Director, Clinical Laboratories; Associate Director,
Professor of Medicine, University of Minnesota, Minneapolis, Hematology Laboratories, Department of Pathology, Montefiore
Minnesota Medical Center, New York, New York
Complications After Hematopoietic Cell Transplantation The Antiphospholipid Syndrome

Jeffrey I. Weitz, MD Deborah Wood, BS MT (ASCP)
Professor of Medicine and Biochemistry and Biomedical Sciences, Project Manager, The EMMES Corporation, Rockville, Maryland
McMaster University, Executive Director, Thrombosis and Investigational New Drug–Enabling Processes for Cell-Based Therapies
Atherosclerosis Research Institute, Canada Research Chair in
Thrombosis, Heart and Stroke Foundation J. F. Mustard Chair in Jennifer Wu, MD, PhD
Cardiovascular Research Hamilton, Ontario, Canada Instructor, Department of Pediatrics, Harvard Medical School,
Overview of Hemostasis and Thrombosis Dana-Farber/Boston Children’s Cancer and Blood Disorders Center,
Hypercoagulable States Boston, Massachusetts
Acute Coronary Syndromes Epigenetics and Epigenomics
Antithrombotic Drugs
Hematologic Problems in the Surgical Patient: Bleeding and Joachim Yahalom, MD
Thrombosis Member and Professor, Radiation Oncology, Memorial Sloan
Kettering Cancer Center, New York, New York
Connie M. Westhoff, PhD Hodgkin Lymphoma: Clinical Manifestations, Staging, and Therapy
Executive Scientific Director, Immunohematology and Genomics,
New York Blood Center, New York, New York Donald L. Yee, MD, MS
Human Blood Group Antigens and Antibodies Associate Professor of Pediatrics, Baylor College of Medicine,
Houston, Texas
Allison P. Wheeler, MD, MSCI Resources for the Hematologist: Interpretive Comments and Selected
Assistant Professor of Pathology, Microbiology, and Immunology Reference Values for Neonatal, Pediatric, and Adult Populations
and Pediatrics, Vanderbilt University, Nashville, Tennessee
Rare Coagulation Factor Deficiencies Anas Younes, MD
Chief, Lymphoma Service, Memorial Sloan Kettering Cancer
Page Widick, MD Center, New York, New York
Chief Medical Resident, Internal Medicine, Brown University, Hodgkin Lymphoma: Clinical Manifestations, Staging, and Therapy
Providence, Rhode Island
Hematologic Manifestations of Malignancy Neal S. Young, MD
Chief, Hematology Branch, National Heart, Lung, and Blood
James S. Wiley, BSc, MD, FRACP, FRCPA Institute; Director, Center for Human Immunology, Autoimmunity,
Principal Research Fellow, Florey Institute of Neuroscience and and Inflammation, National Institutes of Health, Bethesda,
Mental Health, University of Melbourne, Parkville, Victoria, Maryland
Australia Aplastic Anemia
Heme Biosynthesis and Its Disorders: Porphyrias and Sideroblastic
Anemias Michelle P. Zeller, MD
Assistant Professor, Michael G. DeGroote School of Medicine,
Basem M. William, MD McMaster University; Medical Officer, Canadian Blood Services,
Assistant Professor, Department of Internal Medicine, Division of Hamilton, Ontario, Canada
Hematology, The Ohio State University Wexner Medical Center, Diseases of Platelet Number: Immune Thrombocytopenia, Neonatal
Columbus, Ohio Alloimmune Thrombocytopenia, and Posttransfusion Purpura
Pharmacology and Molecular Mechanisms of Antineoplastic Agents for
Hematologic Malignancies